More than 170,000 Register for New Hepatitis C Cure in Egypt

More than 171,000 hepatitis C patients have registered with Egypt’s Health Ministry to receive a cure for hepatitis C (HCV), less than 72 hours after registration opened, said Egypt’s Health Minister. The new hepatitis C pill by Gilead Sciences has arrived in Egypt at more than 99 percent discount to…

Read More

Severe thrombocytopenia in a patient with hepatitis C treated with eltrombopag from off-label drug use to on-label drug use: a case report.

Authors: Al-Jafar HA, Al-Khaldi J, Alduaij A, Al-Banwan K. Source: J Med Case Rep. 2014 Sep 10;8(1):303. [Epub ahead of print] Abstract INTRODUCTION: Off-label drug use refers to drug use beyond the specifications authorized for marketing. Eltrombopag is a new thrombopoietin receptor agonist which was used successfully in this critical…

Read More

Changes in the Epidemiology of Hepatitis A Outbreaks 13 Years after the Introduction of a Mass Vaccination Program from Spain

Authors: Martinez A, Broner S, Sala MR, Manzanares-Laya S, Godoy P, Planas C, et al. Source: Human vaccines & immunotherapeutics. 2014;11(1). Abstract; A hepatitis A+B vaccine vaccination program of 12-year-olds was introduced in Catalonia in 1998. The aim of this study was to investigate the evolution of hepatitis A outbreaks…

Read More